JP2021535210A5 - - Google Patents
Info
- Publication number
- JP2021535210A5 JP2021535210A5 JP2021534420A JP2021534420A JP2021535210A5 JP 2021535210 A5 JP2021535210 A5 JP 2021535210A5 JP 2021534420 A JP2021534420 A JP 2021534420A JP 2021534420 A JP2021534420 A JP 2021534420A JP 2021535210 A5 JP2021535210 A5 JP 2021535210A5
- Authority
- JP
- Japan
- Prior art keywords
- bjmu
- pharmaceutical composition
- bromo
- dimethylphenoxy
- dimethylpentanoic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810965558 | 2018-08-23 | ||
| CN201810965558.1 | 2018-08-23 | ||
| PCT/CN2019/102273 WO2020038464A1 (zh) | 2018-08-23 | 2019-08-23 | 苯氧酸类化合物及其医药用途 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021535210A JP2021535210A (ja) | 2021-12-16 |
| JP2021535210A5 true JP2021535210A5 (https=) | 2024-01-12 |
| JP7472139B2 JP7472139B2 (ja) | 2024-04-22 |
Family
ID=69591994
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021534420A Active JP7472139B2 (ja) | 2018-08-23 | 2019-08-23 | フェノキシカルボン酸化合物およびその医薬用途 |
Country Status (6)
| Country | Link |
|---|---|
| US (2) | US12365643B2 (https=) |
| EP (1) | EP3842410A4 (https=) |
| JP (1) | JP7472139B2 (https=) |
| CN (1) | CN110857268B (https=) |
| AU (1) | AU2019324405B2 (https=) |
| WO (1) | WO2020038464A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113072448B (zh) * | 2021-03-31 | 2022-11-11 | 五邑大学 | 一种芳基吉非罗齐衍生物高价碘化合物及其制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3674836A (en) * | 1968-05-21 | 1972-07-04 | Parke Davis & Co | 2,2-dimethyl-{11 -aryloxy-alkanoic acids and salts and esters thereof |
| US3707566A (en) * | 1970-03-30 | 1972-12-26 | Parke Davis & Co | Aryloxypentane compounds |
| US3759986A (en) * | 1970-03-30 | 1973-09-18 | Parke Davis & Co | Esters of 2,2-dimethyl-5-(aryloxy)-1-pentanols |
| US3847994A (en) | 1970-03-30 | 1974-11-12 | Parke Davis & Co | 2,2-dimethyl-5-(aryloxy)-valeraldehydes |
| EP0462067A1 (en) * | 1990-06-15 | 1991-12-18 | Warner-Lambert Company | Gemfibrozil formulations |
| US5470845A (en) | 1992-10-28 | 1995-11-28 | Bristol-Myers Squibb Company | Methods of using α-phosphonosulfonate squalene synthetase inhibitors including the treatment of atherosclerosis and hypercholesterolemia |
| US5620997A (en) | 1995-05-31 | 1997-04-15 | Warner-Lambert Company | Isothiazolones |
| AU6966696A (en) | 1995-10-05 | 1997-04-28 | Warner-Lambert Company | Method for treating and preventing inflammation and atherosclerosis |
| GB9713739D0 (en) | 1997-06-27 | 1997-09-03 | Karobio Ab | Thyroid receptor ligands |
-
2019
- 2019-08-23 WO PCT/CN2019/102273 patent/WO2020038464A1/zh not_active Ceased
- 2019-08-23 US US17/182,413 patent/US12365643B2/en active Active
- 2019-08-23 EP EP19851778.1A patent/EP3842410A4/en active Pending
- 2019-08-23 JP JP2021534420A patent/JP7472139B2/ja active Active
- 2019-08-23 AU AU2019324405A patent/AU2019324405B2/en active Active
- 2019-08-23 CN CN201910783280.0A patent/CN110857268B/zh active Active
-
2025
- 2025-05-20 US US19/212,924 patent/US20250313522A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6941109B2 (ja) | Ｆｘｒアゴニストを使用するための方法 | |
| JP6986022B2 (ja) | Ｆｘｒアゴニストを使用するための方法 | |
| TWI621624B (zh) | 合成的三萜系化合物及其使用於治療疾病之方法 | |
| JP5925771B2 (ja) | ナイアシン模倣体、およびその使用方法 | |
| KR101996245B1 (ko) | 선택적 s1p1 수용체 아고니스트를 포함하는 약학 조합물 | |
| JP2009537559A5 (https=) | ||
| AU2016269491B2 (en) | Systems, methods, and formulations for treating cancer | |
| RU2005128501A (ru) | Соединение для лечения метаболических расстройств | |
| CA2521621A1 (en) | Compounds for the treatment of metabolic disorders | |
| EA024873B1 (ru) | Терапевтическое средство при дислипидемии | |
| CA2522738A1 (en) | Compounds for the treatment of metabolic disorders | |
| JP7036871B2 (ja) | 光学活性ピラノクロメニルフェノール誘導体およびそれを含む薬学的組成物 | |
| US12128012B2 (en) | Ketamine treatment for amyotrophic lateral sclerosis | |
| JP2013529645A (ja) | ナイアシン模倣体、およびその使用方法 | |
| KR20110117257A (ko) | 트리에틸아세틸기-3-히드록실기페닐기아데노신 및 혈지조절에 대한 용도 | |
| WO2017044551A1 (en) | Ppar-alpha agonists for treating mitochondrial diseases | |
| CA2521589A1 (en) | Compounds for the treatment of metabolic disorders | |
| JP5924699B2 (ja) | 糖尿病の治療薬 | |
| JP5959083B2 (ja) | （１Ｒ−ｔｒａｎｓ）−Ｎ−［［２−（２，３−ジヒドロ−４−ベンゾフラニル）シクロプロピル］メチル］プロパンアミドの代謝物 | |
| JP2021535210A5 (https=) | ||
| US20200223838A1 (en) | Methods of use of phenoxypropylamine compounds to treat depression | |
| JP5017268B2 (ja) | 覚醒を改善する方法 | |
| JP2002356445A (ja) | 多発性硬化症（ｍｓ）、他の脱髄症状ならびに末梢神経障害、特に有痛の神経障害および糖尿病性神経障害の多剤併用治療 | |
| JP2012525362A5 (https=) | ||
| CN101801373B (zh) | 具有抗糖尿病作用的药物组合物 |